Skip to main content

Artezio at Bio-IT World in Boston

Posted on May 14, 2018

Since 2002, the Bio-IT World Conference has played an important role in improving the technological level of healthcare development in the US. Bio-IT is a platform that has been bringing together experts from different fields of science and business for 16 years, allowing them to share ideas and create unique projects. Last year Bio-IT gathered more than 3,400 attendees from 35 countries of the world. This year the organizers expect an even greater number of participants who will be offered 15 conference tracks and various industry workshops. The keynote speakers will include representatives of leading pharmaceutical, healthcare, and technology companies. 

“At the conference, we will outline an implemented system that allows for aggregation of information and data for patients and their diseases. We are creating a research ecosystem, in which clinical and phenotypical data is connected to biobanks,” says Alexander Sherman, Harvard Medical School.   

Enoch S. Huang, Head of Computational Sciences, Pfizer Worldwide Research and Development is planning to talk in his presentation on “Things I Didn’t Know I Needed to Know before Attempting to Implement a Cloud-Based Genomics Data Environment”.

“I will share my experiences in moving genomics data processing and analysis to a public cloud environment and challenges associated with implementation. I am optimistic about the future of this platform and believe this strategy will produce sustainable solutions for pharma R&D,” says Enoch S. Huang, Pfizer Worldwide Research and Development.

Dmitry Rodionov, Business Development Director at Artezio, thinks that Bio-IT is a good platform for building dialog with large businesses.

“Artezio has experience in creating complex healthcare systems. We have developed smart solutions that provide quality monitoring and analysis of medical data in clinics, created a medical management system in a large metropolitan area. Artezio expertise allows us to address market leaders with a proposal of mutually beneficial cooperation, which leads to improving the quality of healthcare services and minimizing costs through high-quality process automation,” says Dmitry Rodionov.